A drug with the SMILES C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CCCC[NH3+])nn3)CC2)nc(N2CCN(C(=O)[C@H](CCCC[NH3+])n3cc(CCC(=O)O)nn3)CC2)n1.[Cl-] has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM of 6.977%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CCCC[NH3+])nn3)CC2)nc(N2CCN(C(=O)[C@H](CCCC[NH3+])n3cc(CCC(=O)O)nn3)CC2)n1.[Cl-]
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CCCC[NH3+])nn3)CC2)nc(N2CCN(C(=O)[C@H](CCCC[NH3+])n3cc(CCC(=O)O)nn3)CC2)n1.[Cl-]
[(5S)-6-[4-[4-[4-[2-[4-(4-azaniumylbutyl)triazol-1-yl]acetyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-5-[4-(2-carboxyethyl)triazol-1-yl]-6-oxohexyl]azanium;chloride